Headquartered in the United States, Protheragen serves as a holistic partner for clinical research and regulatory operations. Our primary objective is to facilitate the advancement of medical therapeutics, pharmaceuticals, and devices through extensive professional expertise and strict adherence to industry guidelines.
A well-maintained quality management system (QMS) serves as the foundational framework required to execute safe, compliant, and effective product development across the pharmaceutical lifecycle. To assist life sciences organizations in navigating increasingly stringent global regulatory requirements, Protheragen provides specialized QMS audits. Our audit services evaluate your organizational processes, identify critical compliance gaps, and deliver objective assessments to help you optimize processes, protect patient safety, ensure data integrity, and remain consistently prepared for regulatory agency evaluations.
Quality is not an isolated event but a continuous process. Protheragen provides comprehensive third-party auditing services to verify that your quality management system is not only documented but effectively implemented and maintained. Our independent status ensures an objective evaluation, free from internal bias, which is essential for identifying systemic vulnerabilities before they impact trial outcomes or regulatory submissions.
We assess internal quality systems across biopharmaceutical companies, CROs, and research institutions to verify alignment with established procedures, regulatory requirements, and GCP standards. These audits help organizations identify systemic vulnerabilities and prevent regulatory risks.
On-site and remote evaluations of your raw material suppliers, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), and service providers to control supply chain quality risks.
Identifying a non-conformance is only the first step; resolving it effectively is critical. Our audits include evaluation of Corrective and Preventive Actions (CAPA) systems to ensure issues are properly documented, investigated, and resolved.
If you are interested in learning more about our QMS audit services or would like to discuss your specific needs, please feel free to contact us. Whether you are preparing for a regulatory inspection, qualifying a new vendor, or strengthening your quality systems, our independent QMS audit team can provide a tailored service.
1. Why should I choose an independent third-party auditor over conducting internal assessments?
Third-party auditors provide an objective perspective that is free from internal influences or operational familiarity. This independence strengthens the credibility of findings and demonstrates to partners and regulators a genuine commitment to impartial quality oversight.
2. How do you select auditors for specialized therapeutic areas?
We assign auditing personnel based on a strict matching of their clinical background with the specific requirements of the project. For complex trials (e.g., advanced therapies or rare diseases), we deploy auditors who understand the unique clinical and operational nuances of that specific field.
3. Can Protheragen assist with the remediation of audit findings?
Yes. While our audit team maintains strict independence and objectivity during the assessment process, a separate consulting division at Protheragen can be engaged post-audit to assist with remediation. This support includes revising standard operating procedures (SOPs), developing targeted training programs, and executing CAPA plans to address identified deficiencies.
4. Will my audit findings and data remain confidential?
Yes. All audit materials, observations, and reports are treated with strict confidentiality. We work under comprehensive confidentiality agreements, and audit results are shared only with authorized client representatives unless otherwise required by predefined disclosure terms.